NCT03319082 - Observational Registry to Assess the Durability of Effect of CXL in Patients With Corneal Ectasia After Refractive Surgery | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

October 4, 2017

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Corneal Ectasia

Interventions

COMBINATION_PRODUCT

Corneal Collagen Cross-linking

Photrexa Viscous (riboflavin 5'-phosphate in 20% dextran ophthalmic solution), Photrexa (riboflavin 5'-phosphate ophthalmic solution), and the KXL System (UV Irradiation).

Trial Locations (11)

19004

RECRUITING

Vantage Eye Care, LLC, Bala-Cynwyd

22102

RECRUITING

See Clearly Vision Group, McLean

29456

RECRUITING

Carolina Cataract & Laser Center, Ladson

43082

RECRUITING

Comprehensive EyeCare of Central Ohio, Westerville

55420

RECRUITING

Chu Vision Institute, P.A., Bloomington

58078

RECRUITING

Vance Thompson Vision - ND, West Fargo

59718

RECRUITING

Vance Thompson Vision - MT, Bozeman

77027

RECRUITING

Slade & Baker Vision, Houston

84020

RECRUITING

Hoopes Vision, Draper

94303

RECRUITING

Stanford University School of Medicine, Palo Alto

98133

RECRUITING

Northwest Eye Surgeons, Seattle